Corbevax, Biological E’s COVID-19 Biological E’s Vaccine Receives Emergency Use Approval For 12-18 Age Group

Share

Tweet

Share

Share

Email

Comments

With this, Corbevax became India’s third homegrown vaccine, to receive an emergency use approval in India for use in adolescents

New Delhi: The Drug Controller General of India (DCGI) on Monday granted an emergency use approval to Hyderabad-based pharmaceutical giant Biological E Ltd’s coronavirus vaccine Corbevax for use in children aged 12 to 18 years. With this, Corbevax became India’s third homegrown vaccine, to receive an emergency use approval in India for use in adolescents.

Drugs Controller General of India (DCGI) grants final approval to Biological E's #COVID19 vaccine Corbevax, for children between 12-18 years of age. pic.twitter.com/ad2xftvmzB

— ANI (@ANI) February 21, 2022